One-step dose increase for house dust mite allergy treatment
Part of Immune system & allergy clinical trials.
This study looks at how safe and well-tolerated a specific allergy immunotherapy treatment for house dust mite allergies is when the dose is increased in one step. If you are already planning to start this treatment, this study helps track how it works in real life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a known allergy to house dust mites, such as allergic runny nose, itchy eyes, or allergic asthma.
- The trial is open to children (ages 5–11), teenagers (ages 12–17), and adults (18 and older).
- Your doctor must have already decided to prescribe this allergy treatment (Novo-Helisen Depot) before you join the study.
- You must be able to give written consent (for minors, both parents or legal guardians must also consent).
- You should not have any medical condition that would make this treatment unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
This trial tests whether a procedure that shrinks the tissue inside your nose (called radiofrequency ablation) plus allergy shots (immunotherapy) helps reduce severe nasal blockage caused by dust mite allergy. It aims to improve breathing and reduce allergy symptoms.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This trial tests a new allergy shot that may reduce symptoms of dust mite allergies, like sneezing, runny nose, and itchy eyes. It might also help with mild asthma caused by dust mites.
This study tests a daily under-the-tongue tablet or drops to reduce allergy symptoms caused by house dust mites. If you have allergic rhinitis and are bothered by dust mites, this treatment might help your nose feel better without needing shots.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
Hear when a new Allergic Rhinitis Due to House Dust Mite trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.